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Objective: Low-intensity cognitive behavioural therapy (LiCBT) can help to alleviate acute 
symptoms of depression and anxiety, but some patients relapse after completing treatment. 
Little is known regarding relapse risk factors, limiting our ability to predict its occurrence. 
Therefore, this study aimed to develop a dynamic prediction tool to identify cases at high risk 
of relapse. 
Method: Data from a longitudinal cohort study of LiCBT patients was analysed using a 
machine learning approach (XGBoost). The sample included n=317 treatment completers who 
were followed-up monthly for 12 months (n=223 relapsed; 70%). An ensemble of XGBoost 
algorithms was developed in order to predict and adjust the estimated risk of relapse (vs 
maintained remission) in a dynamic way, at four separate time-points over the course of a 
patient’s journey. 
Results: Indices of predictive accuracy in a cross-validation design indicated adequate 
generalizability (AUC range = 0.72-0.84; PPV range = 71.2%-75.3%; NPV range = 56.0%-
74.8%). Younger age, unemployment, (non-)linear treatment responses, and residual 
symptoms were identified as important predictors. 
Discussion: It is possible to identify cases at risk of relapse and predictive accuracy improves 
over time as new information is collected. Early identification coupled with targeted relapse 
prevention could considerably improve the longer-term effectiveness of LiCBT. 
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Introduction 
Depression and anxiety disorders are associated with high rates of relapse (<12 months) 
and recurrence (≥12 months) after treatment (Bockting, Hollon, Jarrett, Kuyken & Dobson, 
2015; Bruce et al., 2005; Burcusa & Iacono, 2007; Hardeveld, Spijker, De Graaf, Nolen & 
Beekman, 2010; Vervliet, Craske & Hermans, 2013). Patients who complete cognitive 
behavioural therapy (CBT) tend to have lower relapse rates compared to those who discontinue 
pharmacological treatment (Cuijpers et al., 2013; Hollon, Stewart & Strunk, 2006; Otto, Smits 
& Reese, 2005; Vittengl, Clark, Dunn & Jarrett, 2007). Despite this, relapse remains common 
after CBT for both depression and anxiety. For example, a meta-analysis estimated that 29% 
of patients with depression who completed CBT with remission of symptoms relapse within 
one year, with this increasing to 54% within two years when recurrence events are considered 
(Vittengl et al., 2007). More recently, a longitudinal cohort study also found that many patients 
relapse after completing the low-intensity version of CBT (i.e. brief, structured, guided 
psychoeducational self-help interventions based on CBT principles; LiCBT), as applied in the 
Improving Access to Psychological Therapies (IAPT) programme in England (Ali et al., 2017; 
Clarke, 2011). Specifically, they estimated that 53% of patients with depression and/or anxiety 
that complete LiCBT relapse within one year, with a further 13% experiencing a recurrence in 
the following year (Ali et al., 2017; Delgadillo et al., 2018). Therefore, it is important to 
understand what risk factors are associated with relapse after CBT, as many patients who 
complete therapy with remission of symptoms do not maintain their treatment gains long-term. 
However, relatively little is known about factors associated with relapse after CBT for 
depression and anxiety disorders. A recent systematic review identified only two well-
supported and replicated predictors of depressive relapse: residual symptoms, and previous 
number of depression episodes (Wojnarowksi, Firth, Finegan & Delgadillo, 2019). Despite the 
investigation of over twenty variables across studies included in this review, most studies were 
grossly underpowered to identify reliable predictors of relapse, especially in samples with a 
low event base-rate. Furthermore, these studies applied suboptimal analyses to perform 
variable selection in samples with multiple features, and to deal with multicollinearity when 
correlated features were examined as potential predictors of relapse. Contemporary machine 
learning approaches could potentially help to advance our understanding of relapse risk factors, 
since they are explicitly designed to optimize variable selection and to enhance predictive 
accuracy by leveraging the prognostic signal across multiple “weak” predictors (Hastie, 
Tibshirani & Friedman, 2009). 
 In supervised machine learning, patterns are identified in data with the goal of using 
input variables to predict the values of a target outcome measure (Hastie et al., 2009). Such 
models are often trained to maximize generalizability to new samples. In contrast to traditional 
statistical models, such as general linear model (GLM) approaches, supervised machine 
learning approaches focus on prediction rather than explanation (Yarkoni & Westfall, 2017). 
This focus provides certain advantages over GLM. For instance, the predictive accuracy of 
GLM equations is known to be limited when they are developed using relatively small samples 
and a large number of predictor variables (Iniesta, Stahl & McGuffin, 2016). Furthermore, 
GLM approaches are prone to overfitting (Babyak, 2004; Yarkoni & Westfall, 2017). This 
refers to situations where a prediction model is overly influenced by the idiosyncrasies of the 
cases used to develop it (i.e., it incorporates noise that is unique to this sample), and is 
consequently unreliable at predicting outcomes in new samples (i.e., poor generalizability). 
Machine learning approaches address overfitting by implementing cross-validation (i.e., 
training models and then examining their predictive ability in test samples) and regularization 
methods (i.e., penalizing overly complex models; Hastie et al., 2009).  
 Machine learning approaches have recently been utilized to address a series of mental 
health related prediction problems. For example: the prediction of persistent depressive 
symptoms in older adults (Hatton et al., 2019); the diagnosis of post-traumatic stress disorder 
(PTSD) three months after a severe injury (Papini et al., 2018); response to pharmacological 
treatment of depression (Chekroud et al., 2016); and targeted prescription of alternative 
psychological treatments for depression (Cohen, Kim, Van, Dekker & Driessen, 2019; 
Delgadillo & Gonzalez Salas Duhne, 2020). Set against this backdrop of emerging applications 
of machine learning in mental health, the present study aimed to (a) identify prognostic 
indicators of relapse after LiCBT and (b) to use this information to develop a relapse prediction 
tool that could be used to guided relapse prevention interventions in psychological services. 
Method 
Design, Setting and Interventions 
This study analyzed data from the WYLOW study (Delgadillo et al., 2018), which was 
a naturalistic, prospective, longitudinal cohort study. N=439 LiCBT patients with remission of 
depression and anxiety symptoms after treatment were recruited into the study from a 
psychological therapy service in West Yorkshire, England, which was part of the IAPT 
programme (Clark, 2011). Participants were followed-up on a monthly basis after treatment 
completion, for up to 24 months. The overall objective of the study was to quantify relapse and 
recurrence rates after routinely-delivered LiCBT. Approval for the study was obtained from 
the NHS Health Research Authority and an independent ethics committee (Ref: 12/YH/0095). 
Participants in the WYLOW study completed low intensity guided self-help 
interventions based on principles of CBT, which was consistent with national clinical 
guidelines and competency frameworks (National IAPT Team, 2015; National Institute for 
Health and Clinical Excellence, 2011). These interventions were delivered in one-to-one 
sessions, group settings, or via computerized CBT programmes with adjunct telephone support. 
LiCBT in this service was highly standardized, protocol-driven, and delivered by qualified 
psychological wellbeing practitioners (PWPs) who practiced under regular clinical supervision 
(weekly, or every other week).  
LiCBT patients who completed treatment with sub-clinical depression and anxiety 
symptoms (see measures section) were eligible for inclusion and were recruited within one 
month of their last planned treatment session. Participants were contacted by independent 
researchers on a monthly basis and prompted to complete depression and anxiety 
questionnaires via email, telephone or postal survey (based on participants’ preferences). 
Participants remained in the study until they met one of three criteria: (1) they were classified 
as having relapsed (as defined below); (2) they had failed to respond to two consecutive 
monthly assessments (lost to follow-up); or (3) their responses indicated that they had remained 
in remission throughout the follow-up period. Participants that were classified as having 
relapsed were provided with self-help information and supported to re-engage with mental 
healthcare services. Further details about the study setting, design, recruitment process, data 
collection and primary findings are reported elsewhere (Ali et al., 2017; Delgadillo et al., 2018). 
Although the WYLOW study collected data for up to 24 months post-treatment, this 
study only analyzed data from the initial 12 month period. There were two reasons for this: 1) 
this study’s purpose was to predict relapse (<12 months), not recurrence (≥12 months); and 2) 
the inclusion of recurrence events in the analysis would have limited the number of cases that 
remained in remission throughout the follow-up period to a point where the development of 
predictive algorithms would have been unfeasible. 
Participants 
The present study sample analyzed data for a subsample of n=317 cases from the 
WYLOW study, excluding n=122 cases that were lost to follow-up, and for whom the actual 
outcome of interest (relapsed or maintained remission) was unknown. Within the first half of 
the follow-up period, n=84 participants had relapsed after one month, n=125 after two months, 
n=155 after three months, n=171 after four months, n=178 after five months, and n=189 after 
six months. Within the second half, n=196 cases had relapsed after seven months, n=202 after 
eight months, n=208 after nine months, n=214 after 10 months, n=218 after 11 months, and 
n=223 after one year. Therefore, a total of n=223 (70%) cases in the present study sample 
relapsed during the 12-month follow-up period, while n=94 remained in remission. 
The three most common primary presenting problems recorded in clinical records for 
the above cases were mixed anxiety and depression (32%); depressive episode (22%); and 
generalized anxiety disorder (19%). Other mental health problems (e.g., panic disorder, 
obsessive compulsive disorder) were recorded as the primary problem for less than 3% of cases 
each (n<10). The sample was characterized by a majority of female patients (59%) from a white 
British background (90%), with a mean age of 43 (SD = 14.8). Approximately 10% were 
unemployed at the start of treatment, 12% were unemployed at the end, 11% had a self-reported 
disability, and 26% had a self-reported long-term medical condition (e.g., asthma, diabetes, 
chronic pain, etc.). Patients accessed a mean of seven LiCBT sessions (SD = 2; range = 2-16). 
Measures 
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & William, 2001): A 
screening tool for major depression containing nine items. Each item assesses how often a 
specific symptom is experienced over a two-week period and is measured on a 0-3 scale (i.e. 0 
= “not at all”, 3 = “nearly every day”). Responses are summed to calculate an overall severity 
score (range = 0-27). A cut-off of ≥10 is recommended to detect clinically significant 
depression symptoms (Kroenke et al., 2001). 
 Generalized Anxiety Disorder scale (GAD-7; Spitzer, Kroenke, Williams, & Love, 
2006): A screening tool for anxiety disorders containing seven items. Similar to the PHQ-9, 
each item assesses how often a symptom is experienced by over a two-week period and the 
same scale (i.e. 0-3) is used. Responses are summed to calculate an overall severity score (range 
= 0-21), and a cut-off of ≥8 is used for the detection of an anxiety disorder (Kroenke, Spitzer, 
Williams, Monahan, & Löwe, 2007). 
 In order to monitor deterioration over time, a reliable change index of ≥5 for both the 
PHQ-9 (McMillan, Gilbody & Richards, 2010) and the GAD-7 (Richards & Borglin, 2011) 
was applied in this study. 
 Work and Social Adjustment Scale (WSAS; Mundt, Marks, Shear & Greist, 2002): A 
questionnaire that assesses the impact of a mental health problem on five life domains (work, 
home management, social life, leisure activities, family and relationships). The impact on each 
domain is measured on 0-8 scales (i.e. 0 = “no impairment”, 8 = “severe impairment”), and the 
five scores are summed to derive an overall score of functional impairment (range = 0-40). 
 A series of other clinical, demographic and treatment variables were also available. 
These are described in detail by Ali et al. (2017) and summarized in Table 1. 
Primary Outcome 
For a patient to be classed as having relapsed, the following two criteria must have been 
met: (a) at least one of the symptom measures (PHQ-9 or GAD-7) was above the clinical cut-
off at a monthly follow-up review; and (b) the measure was indicative of statistically reliable 
deterioration relative to the score observed at the final treatment session (based on the reliable 
change index). Patients who scored above clinical cut-offs during the follow-up period 
(criterion a) but did not display statistically reliable deterioration (criterion b), were not classed 
as having relapsed and continued to be monitored on a monthly basis. Fourteen of the 94 
participants who remained in remission after 12 months had met criterion a but not criterion b 
at least once during the follow-up period. 
Analysis 
A supervised machine learning approach was applied to develop an ensemble of four 
prognostic models that aimed to predict relapse in a dynamic (longitudinal) way during the 
treatment and follow-up phases. Each successive model was trained using additional 
information that became available over time, thus enabling the overall ensemble of algorithms 
to “learn” to “adjust” the prognosis in four steps. Model 1 used information only known at the 
time of pre-treatment assessments; Model 2 learned from information known at the final 
treatment session: Model 3 included information available one month after the end of 
treatment; and Model 4 included information available three months after the end of treatment. 
These models were trained to output a predicted classification for each patient (1 = will relapse 
within 12-months of completing treatment; 0 = will have sustained remission for up to 12 
months), at each relevant time-point described above. Importantly, the dynamic nature of this 
overall modelling approach means that a case predicted at one time-point (e.g., last treatment 
session) to maintain remission could later be classed as at risk of relapse based on newly 
available information (e.g., if depression symptoms increase at 3-months follow-up).  
No models were developed that used information collected after three months of 
follow-up as predictors of relapse, as these models would have been too underpowered due to 
the gradual decrease of the overall sample during the follow-up period. Indeed, due to this 
gradual decrease, Models 3 and 4 (i.e., predictions occurring during follow-up) were developed 
using smaller overall samples than Models 1 and 2 (i.e., predictions occurring before follow-
u). The variables tested as potential predictors in each model are summarized in Table 1, and 
further described in Supplementary Materials A (glossary of terminology). The potential 
predictors ranged from baseline characteristics to factors related to treatment response. 
Machine learning approach. We applied extreme gradient boosting (XGBoost; Chen 
& Guestrin, 2016), as implemented in the R package xgboost (Chen et al., 2019), to develop 
the four prognostic models. The XGBoost package implements gradient-boosted decision trees 
(Friedman, 2001). Gradient boosting is an ensemble machine learning approach, meaning that 
it combines several simple decision trees, that are each individually poor at predicting an 
outcome, to develop one collective, stronger prognostic model. Specifically, when each 
successive decision tree is trained, subsequent trees learn from the ‘residuals’ or ‘errors’ from 
the previous modelling attempt. Therefore, each gradient boosting model is developed 
iteratively in multiple steps, with each step placing more priority in making accurate 
predictions for those individuals for whom prior iterations made poor predictions. 
Each single decision tree consists of ‘branches’, which represent logical structures. 
Each study participant has a ‘path’ through a decision tree that is determined by their data; for 
dichotomous features (e.g., employed/unemployed), paths diverge for yes/present or no/absent 
responses, while for continuous features (e.g., baseline depression severity), paths diverge 
based on empirically derived cut-offs. Different cut-offs are examined by the algorithm until a 
final cut-off is selected based on the optimization of predictive accuracy. Each path terminates 
at a ‘leaf’, which represents a predicted probability weight for the outcome of interest. The 
final predicted classification (relapse/sustained remission) for each case is derived by summing 
their individual probability weights across all decision trees in the ensemble. An example 
decision tree, extracted from a model developed in this study, is illustrated in Figure 1. 
XGBoost has several advantages over conventional regression modelling (Chen & 
Guestrin, 2016). For instance, missing data does not need to be imputed or excluded, as the 
algorithm can use missing data as an informative splitting criterion. Moreover, continuous 
variables do not need to be transformed, as path divergences are established based on cut-offs 
determined by the algorithm. Gradient boosting allows for complex, non-linear interactions 
among categorical and continuous variables to be incorporated into predictive models. In 
addition, XGBoost can also minimize overfitting through the implementation of L1 (LASSO) 
and L2 (Ridge) regularization procedures, and cross-validation loops. 
 Parameters. For the development of each of the four models, hyperparameters were set 
for the implementation of XGBoost. One parameter, eta, controls the learning rate of the 
algorithm, and can minimize overfitting by shrinking the weights of variables after each 
boosting step, thus making the boosting process more conservative. Eta can range from 0-1, 
and was manually set in this study at 0.1. Another parameter manually set was the maximum 
depth of a tree, which was set at 3. This meant that during the development of each individual 
decision tree, there can only be a maximum of two further ‘branch splits’ along a path after the 
initial split. Trees with larger depths are more complex and allow models to learn relations that 
are highly specific to a particular sample. Therefore, having a smaller maximum depth for trees 
minimizes overfitting. We used the XGBoost default values for regularization, where alpha 
(L1) is set to 0 and lambda (L2) is set to 1. Therefore, no LASSO regularization was applied 
in the development of predictive models, while a Ridge penalty was applied. 
The evaluation metric used to assess the predictive ability of models was the area under 
the receiver operating characteristic curve (AUC). This measure assesses how capable models 
are at distinguishing between binary outcome classes (Bradley, 1997). The metric ranges from 
0-1, with 1 representing a perfect predictive model and 0.5 indicating that predictions are no 
better than chance. The AUC statistic has been recommended as an appropriate evaluation 
metric for healthcare research, due to the clinical utility of model predictions being more 
important than statistical power in these contexts (Moons et al., 2015). 
Internal cross-validation. Internal cross-validation loops were used to develop an 
XGBoost ensemble model. To achieve this, the overall sample was partitioned into five 
subsamples using stratified randomization so that each subsample had approximately the same 
rate of relapse cases. Each loop would use 4/5 of the data as a training sample and 1/5 as a test 
sample. Each subsequent decision tree was trained using this five-fold cross-validation process, 
which continued until a ‘stopping rule’ was triggered if the addition of new trees resulted in 
overfitting with reference to the AUC observed in the test sample. The cross-validation process 
therefore identified the highest number of decision trees an XGBoost model can incorporate 
before overfitting to the dataset. 
Variable selection. Implementation of XGBoost produces a model with: (1) a final 
AUC statistic that assesses its ‘out-of-sample’ performance; and (2) information regarding the 
variables that the model has selected for use in making its predictions. It is desirable to train a 
model with the highest possible AUC index, and with the lowest number of variables selected 
(i.e., a more parsimonious model). If superfluous variables are made available to the algorithm, 
then given the large number of decisions the model must take, it will occasionally happen 
across a subset of data for which these extra variables appear to be predictive but do not extend 
to the test set. Thus, we can improve the model by iteratively testing whether removing a 
variable from the dataset improves the AUC index. 
We therefore performed variable selection through the additional incorporation of 
‘leave-one-variable-out loops’. One loop involved additional XGBoost models to be 
developed, with the same number of models being developed as there were variables input into 
the base model (k). For each of the models produced in this step of model development, one 
different variable was excluded from analysis and therefore not incorporated into the model 
(i.e., k-1). The model with the highest associated AUC statistic was considered the best model 
in this step of the process, and kept for further development. Following this, another leave-one-
out loop was implemented using the variables included in the best model from the previous 
loop, and this process continued until there was only one variable remaining. The model with 
the highest AUC across all of the loops was considered the best overall model developed. This 
incorporation of leave-one-out loops ensured that the final selected model had the highest AUC 
possible with the lowest number of variables involved.  
Model evaluation. The analytical process described thus far was followed to develop 
each of the four prognostic models (Models 1-4). Using each of these models, predicted 
probabilities of relapse for each patient were calculated at four time-points during their pathway 
through treatment and follow-up. Probabilities ranged from 0-1 with higher scores indicating 
greater probability of relapse, and a patient was predicted to relapse when their calculated 
probability was greater than 0.5. Conventional performance metrics were calculated to assess 
the predictive value of each model when tested out-of-sample (in the 1/5 test set): accuracy; 
sensitivity; specificity; positive predictive value (PPV); and negative predictive value (NPV). 
Exploring individual predictors. Before individually exploring the predictors identified 
by each model, a sensitivity analysis was conducted in which the four final models were 
reanalyzed with the application of L1 regularization (alpha=0.5). In contrast to L2 
regularization, L1 regularization is capable of shrinking the coefficients of variables to be 
exactly zero, thus eliminating likely irrelevant variables from the model (Hastie, Tibshirani & 
Friedman, 2009). Therefore, this sensitivity analysis was conducted to explore if the addition 
of a LASSO penalty identified any variables in the models as being spurious or potential false 
positives, and thus ensure that only the most important individual predictors were explored.  
Following this, the variables that were (1) determined to be important by at least one of 
the four final XGBoost models, and (2) not deemed spurious by the addition of L1 
regularization, were explored in terms of their associations with relapse using relative 
importance metrics, partial dependence plots, and descriptive statistics. Relative importance is 
a metric that indicates how useful a predictor was in the construction of boosted decision trees 
within a model, relative to the other predictors used by the model. It is calculated for each 
predictor by assessing the degree to which a model’s predictive ability improves when key 
decisions within decision trees use that specific variable (Hastie, Tibshirani & Friedman, 2009). 
Meanwhile, partial dependence plots demonstrate the relationship between a predictor and the 
outcome by aggregating all of the decisions in all of the decision trees in the model which select 
on that predictor (Friedman, 2001). Therefore, they illustrate the relationship that the XGBoost 
model judges is directly attributable to that predictor, after partialling out the effects of other 
predictor variables, even if they might be correlated with the predictor of interest. 
Results 
Performance of XGBoost Models 
The predictive value of the four models when evaluated on the test set is summarized 
in Table 2. The AUC became larger as more information was available to the models over time. 
Model 1, which only used pre-treatment assessment information, had the lowest AUC (0.72), 
while Model 4, which used information available up to the third month of post-treatment 
follow-up, had the highest AUC (0.84). Other metrics of predictive value displayed in Table 2 
indicated that Models 1 and 2 had highly similar performances. Both models had high 
sensitivity (91% and 90.1% respectively), PPV (74.9% and 75.3% respectively), and accuracy 
(both 72.2%). However, both models also had low specificity (27.7% and 29.8% respectively) 
and NPV (56.5% and 56% respectively). Model 3 was found to have greater specificity (52.1%) 
and NPV (63.6%), however it also had the lowest accuracy (68.7%) and PPV (71.2%) of all 
four models, and the second lowest sensitivity (79.9%). Overall, Model 4 was found to have 
the best relative balance in performance indices across all four models. The distributions of the 
probabilities of relapse predicted by each model for each patient can be seen in Figure 2. 
Important Predictors 
Of the 141 variables input as potential predictors of relapse across all four models, a 
total of 42 predictors were deemed important. Model 2 was the most complex, selecting 13/32 
input variables as important predictors. Models 3 and 4 each identified 11 predictors as 
important, with 39 and 53 variables initially being entered into each model respectively. 
Finally, Model 1 was the simplest, selecting only seven of the 17 variables initially entered into 
the model. The predictors identified as being important by each model, and the relative 
importance of each variable for the prediction of relapse, are displayed in Table 3.  
The sensitivity analyses (i.e., re-analysis of the final models with L1 regularization 
applied) yielded models with similar but slightly lower cross-validated AUC indices. They also 
retained the same number of important predictors for Models 2, 3, and 4. However, the 
sensitivity analysis for Model 1 did not select the variable denoting missing vs. complete 
response to the treatment expectancy variable as an important predictor, indicating that this 
variable is likely to be spurious. Therefore, this variable was not explored further. For the sake 
of parsimony, the important predictors can be grouped according to four categories: 
demographics; baseline clinical features; treatment process features; and residual symptoms. 
Partial dependence plots can be found in Supplementary Materials B. 
Demographics. Demographic predictors leveraged a combined importance (i.e. the sum 
of relative importance metrics of each predictor of the same type) of 63% in Model 1, however 
this decreased when subsequent models had access to further information. Demographic 
predictors only had 30% combined importance for Model 2, 37% for Model 3, and 11% for 
Model 4. Younger age, unemployment (pre-treatment and post-treatment), disability, and 
female gender featured as important predictors across at least two models (the latter two 
features had relatively little importance). Unemployment was a particularly important risk 
factor, with all 31 participants who were unemployed before starting treatment relapsing within 
12 months, and 37/39 participants who were unemployed at the end of treatment relapsing. 
Baseline clinical features. Pre-treatment clinical features had a combined importance 
of 37% for Model 1, 15% for Model 2, and 14% for both Models 3 and 4. The following risk 
factors were selected as important by at least two models: use of psychotropic medication at 
the start of treatment, and family history of mental health problems. Both features had 
comparatively small importance indices. Six other baseline clinical features were deemed 
important by only one model each: higher baseline WSAS severity, higher baseline GAD-7 
severity, previous treatment episodes, low expectancy of treatment, diagnosis of an affective 
or an anxiety disorder (vs a ‘mixed’ or ‘other’ diagnosis), and a chronic mental health problem. 
 Treatment process features. Treatment process features were only relevant to Models 
2-4, since Model 1 only included pre-treatment information. The combined importance of these 
features was 40% in Model 2, 0% in Model 3 and 11% in Model 4. The following risk factors 
were selected as important in two models: early treatment response (higher improvement by 
session 3) in the PHQ-9 measure, a more linear (versus nonlinear) trajectory of improvement 
in the WSAS measure during treatment, and a more nonlinear (versus linear) trajectory of 
improvement in GAD-7. However, early treatment response had less importance compared to 
the latter two features, while the findings for the GAD-7 measure were relatively inconsistent 
and less clear from the partial dependence plots than the findings for the WSAS measure. 
 Residual symptoms. The combined importance of residual symptoms (sub-threshold 
symptom scores close to the diagnostic cut-offs) post-treatment was only 15% for Model 2, 
however this increased to 48% and 47% for Models 3 and 4 respectively. Higher post-treatment 
scores and increases in PHQ-9, GAD-7 and WSAS scores between the last treatment session 
and follow-up assessments were selected as important predictors across at least two models. 
Discussion 
This study demonstrates the utility of a data-driven prognostic method capable of 
identifying cases at high risk of relapse after the completion of LiCBT. Previous studies have 
used traditional statistical models to predict relapse after routinely delivered CBT interventions 
(see review by Wojnarowski et al., 2019). The present study represents a novel and 
considerable advance in this line of research through the application of a machine learning 
ensemble of models that dynamically predict and adjust expected prognoses at multiple time-
points during the course of a patient’s treatment journey. The AUC statistics for these models 
ranged from 0.72-0.84, with predictive accuracy tending to improve over time, when models 
were trained using more information. The best performance (AUC = 0.84) was observed for 
Model 4, which used information collected before treatment, at the end of treatment, and up to 
the third month of post-treatment follow-up. This is likely to be explained by the use of the 
maximum number of available predictors, but also due to the temporal proximity of the 
prediction time-point to the target outcome. A close examination of performance metrics across 
these models indicated that positive predictive values were superior to negative predictive 
values. Put simply, these models performed well at identifying cases at high risk of relapse, but 
they were less capable of accurately identifying patients that would maintain remission of 
symptoms during the 12-month follow-up period. However, this was not the case for Model 4, 
which had both high PPV (74.6%) and high NPV (74.8%). 
In terms of predictor categories, demographic and baseline clinical features exhibited 
high importance in the early models. However, this decreased in later models when additional 
variables related to the therapeutic process and residual symptoms were also included. Residual 
symptoms had by far the highest combined importance of the four categories in Models 3 and 
4, having the greatest temporal proximity to the target outcome. In contrast, although 
therapeutic process features had high combined importance in Model 2, they had no importance 
in Model 3, and little importance in Model 4. This inconsistent pattern may indicate limited 
robustness of the findings related to these features, and thus further research is required. 
Specific patient features that were most informative for the prediction of relapse 
included younger age, unemployment, treatment response trends (linear versus nonlinear), and 
the presence of residual symptoms. Young age was identified as a risk factor, contrary to prior 
studies in this area (Evans et al., 1992; Lincoln et al., 2005; Heldt et al., 2011). However, 
previous studies had less than n=20 relapse cases in their samples, indicating that they were 
grossly underpowered to detect even a large effect size. Indeed, a relatively larger study (n=31 
recurrence cases) conducted by Fava et al. (2001), found a significant effect of young age on 
recurrence of panic disorder with agoraphobia after exposure-based treatment. 
Unemployment was a highly important risk indicator in the current sample, with all 31 
participants who were unemployed at the start of treatment being classed as having relapsed 
within 12 months. In addition, the majority of these relapse cases occurred in the first month 
of follow-up, indicating that the time-to-relapse was accelerated for unemployed patients. 
Interestingly, cases that were unemployed before treatment did not entirely overlap with cases 
unemployed at the end of treatment, yet unemployment at both time-points was identified as a 
risk factor. This indicates that any experience of unemployment during the therapy process 
increases a patient’s risk of relapse. This adds further credibility to the wealth of evidence 
concerning the harmful effects of unemployment on mental health (Waddell & Burton, 2006).   
Patterns of change during treatment were also informative for relapse prediction. 
Patients who displayed a rapid reduction of depression symptoms during the first 3 sessions 
had higher risk of relapse. Although early response is a well-established predictor of end-of-
treatment outcomes in psychotherapy, a recent systematic review suggested that this could be 
at least partly influenced by a quasi-placebo effect, since rapid response is also evident in 
placebo control groups (Beard & Delgadillo, 2019). It is, therefore, possible that patients with 
early response may mostly be improving due to a remoralisation effect (Howard, Lueger, 
Maling, & Martinovich, 1993), but remain at risk of relapse because their learning of coping 
strategies has not been sufficiently developed or consolidated. A linear improvement in 
functional impairment over the course of treatment also appeared to predict relapse. Previous 
studies on the relationship between treatment duration and clinical outcomes suggest that 
domains such as interpersonal and social functioning tend to improve at later stages of 
treatment (see review by Robinson, Delgadillo, & Kellett, 2019). Therefore, a gradual and 
linear improvement in functioning in relatively brief interventions (less than 8 sessions) 
possibly indicates that such changes may possibly be due to the temporary resolution of life 
problems and current stressors rather than therapy, leaving patients at risk of relapse when 
future stressors arise if they have not had an opportunity to consolidate coping skills. Findings 
concerning trajectories of anxiety symptoms were mixed and therefore an interpretation of 
these patterns would be premature at this stage and warrants further investigation.    
The identification of residual symptoms after treatment as an important predictor of 
relapse is consistent with previous research (Bockting et al., 2015; Wojnarowski et al., 2019). 
One proposed explanation is that residual symptoms represent the persistence of the underlying 
disorder, albeit in a milder form (Paykel, 2008). Another possibility is that the presence of 
residual symptoms is associated with a greater vulnerability to experiencing future life events 
as intolerably stressful and de-stabilizing, thus increasing the likelihood of relapse (Harkness, 
Theriault, Stewart & Bagby, 2014).  
Limitations and Future Research 
 A limitation concerning the study sample concerns class-imbalance (i.e., the number of 
observations belonging to each outcome class was not the same), since relapse cases in this 
sample outnumbered remission cases (223 versus 94). Class-imbalance can undermine the 
accuracy of machine learning algorithms, with poorer predictive accuracy for patients in the 
minority class (Lopez, Fernandez, Garcia, Palade & Herrera, 2013). Indeed, Models 1 and 2, 
which were both developed using the total class-imbalanced sample, were highly effective at 
classifying relapse cases correctly (high PPV), but less capable of classifying remission cases 
accurately (low NPV). In contrast, Models 3 and 4, which were developed using smaller, more 
balanced samples, had an improved ability to accurately predict remission cases (higher NPVs). 
This pattern (Figure 2) may be influenced by class-imbalance bias. Therefore, Model 4 being 
superior at prediction compared to the other models may not be because prediction of relapse 
is most accurate during follow-up, but rather an artifact of class-imbalance.   
One potential solution for attenuating class-imbalance bias is to adopt resampling 
techniques. One such technique is over-sampling, in which the skewed distribution is addressed 
by generating new minority class observations (e.g. synthetic minority over-sampling 
technique [SMOTE]; Chawla, Bowyer, Hall & Kegelmeyer, 2002). A different technique is 
under-sampling, in which observations from the majority class are discarded instead (e.g. 
Random Undersampling; Tahir, Kittler, Mikolajczyk & Yan, 2009). The technique that is most 
appropriate may depend on the form of class-imbalance exhibited by a sample (Haixiang et al., 
2017). Future replications of this study that also use class-imbalanced samples should consider 
using resampling techniques to limit this bias and improve model development. In the current 
study, we chose not to apply such methods to minimize modelling complexity since the primary 
goal was to test the accuracy of dynamic prediction models, but also because it is instructive to 
show the effects of class-imbalance so as to inform future research. 
Another important limitation is that this study only applied an internal cross-validation 
loop, with the models being evaluated on subsamples that were also involved in the training of 
the models. Although internal validation can provide an indication of how models may 
generalize to new samples, a more robust method to determine out-of-sample generalizability 
is to apply an additional external validation in a statistically independent sample that was not 
involved in model development (Steyerberg, Bleeker, Moll, Grobbee & Moons, 2003). This 
can be done using a ‘holdout’ subsample of the overall original sample, which was not possible 
in this study due to the limited sample size, and/or using a sample of participants from a 
different population altogether (but for whom the same variables are available). Applications 
of machine learning algorithms using this rigorous external cross-validation process in mental 
healthcare research have shown that out-of-sample predictions tend to be valid and clinically 
useful, but less accurate in new samples (Chekroud et al., 2016; Delgadillo & Gonzalez Salas 
Duhne, 2020; Delgadillo, Huey, Bennett, & McMillan, 2017; Leighton et al., 2019). 
There were additional limitations related to the population investigated and data 
collection methods used. For instance, loss-to-follow-up in the primary study sample meant 
that data from 122 participants were not taken into account in the development of the present 
models. Furthermore, participants only received LiCBT interventions, so these models may not 
apply to patients who receive high-intensity CBT. In contrast to high-intensity CBT, LiCBT 
interventions are brief, highly manualized, non-specialist, and driven by the use of highly 
structured psychoeducational workbooks (Bennett-Levy, Richards & Farrand, 2010). Due to 
these differences, it is plausible that there are differences between the two therapeutic formats 
in terms of the processes that underlie relapse. Therefore, further research needs to explore any 
potential differences between LiCBT and high-intensity CBT in terms of predicting relapse, 
and in terms of the individual risk factors associated with relapse. Another limitation of this 
study was the lack of an assessment of treatment fidelity or competency, thus making it 
impossible to know if PWPs had adhered to LiCBT treatment protocols. A recent study has 
developed and validated two measures for the purposes of assessing LiCBT competencies 
(Kellett et al., 2020). These measures could be applied in future research. 
 Future research into the prediction of relapse should also investigate predictors that 
were not considered in this study. For example, previous research has indicated that the 
experience of stressful life events during follow-up increases the risk of relapse for both 
depression and anxiety (Harkness et al., 2014; Heldt et al., 2011). Use of experience sampling 
methods using mobile-phone and passive sensing technology could be fruitful to track life 
events and/or physiological and subjective responses to such events. 
Clinical Implications 
 This study highlights the need for relapse prevention to be a core component of low-
intensity CBT interventions. Although relapse prevention is considered an important aspect of 
LiCBT (Rodgers et al., 2012), the lack of treatment fidelity measures being applied means we 
do not know if this essential component of treatment is being delivered. Furthermore, this study 
also highlights the importance of providing relapse prevention interventions. Although offering 
these interventions incurs a financial cost, the effective prevention of relapse has been argued 
to save money in the long-term, due to a reduction in the ‘revolving door’ phenomenon where 
patients continually return for further treatment (Scott, Palmer, Paykel, Teasdale & Hayhurst, 
2003; Wojnarowski et al., 2019). Furthermore, the development of prognostic algorithms using 
machine learning approaches potentially allows for patients at risk of relapse to be identified 
and targeted with maintenance interventions. If such algorithms were to be implemented in 
psychological services, it is important that models can effectively identify both patients who 
are vulnerable to relapse, and those who are not. This is to ensure that the prescription of these 
interventions is provided to patients that are in need of them, but also performed in a cost-
effective manner (i.e. not offered to every patient who successfully responds to treatment). 
Therefore, Models 1 and 2 may be inappropriate for application in clinical contexts due to these 
models possessing low NPVs, although these models could potentially be improved with 
further research that utilizes larger, class-balanced samples. In contrast, Model 4 would be the 
most appropriate model for use in clinical contexts, due to it possessing a good balance between 
high PPV and NPVs. However, Model 4 is limited by not being able to predict relapses that 
occur in the first three months of follow-up. Model 4 possessing the greatest predictive power 
may indicate that follow-up appointments improve our ability to understand and predict 
relapse. Incorporating structured follow-up into clinical practice would allow for prognostic 
algorithms such as Model 4 to be applied by clinicians, while also enabling larger datasets to 
be constructed and thus allow more improved predictive models to be developed. 
Conclusions 
 This study demonstrates that it is possible to identify cases at high risk of relapse using 
routinely available data, with considerable accuracy even before the start of treatment, and 
predictive accuracy improving as new information becomes available over time. This dynamic 
prognostic system could be used in routine care to identify ‘high risk’ cases that could be 
offered evidence-based relapse prevention interventions in a targeted way, thus making best 
use of limited resources in publicly funded mental health services. 
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